Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Endurance exercise may help BPH by lowering hormones and inflammation.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Metabolic syndrome worsens treatment outcomes for urinary symptoms in men with enlarged prostate.

Finasteride reduces prostate size and symptoms with few side effects.

Finasteride may reduce prostate cancer risk.

These medications for BPH have known risks and may have new side effects.

Alpha-blockers are recommended first for recent CP/CPPS, while antimicrobials are not advised for long-term cases.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.